technology with the Medtronic automated insulin delivery (AID) and smart insulin pen systems. This collaboration is set to ...

Medtronic plc’s MDT strength in the Cardiovascular ... lost 5.3% against the industry’s 5.3% growth in the past year. PEN’s earnings surpassed estimates in three of the trailing four ...

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...

Noteworthy is Medtronic's FDA-cleared smart insulin pen that integrates glucose sensor data, utilizing AI to personalize insulin dosing. From an investor’s perspective, the healthcare sector ...